Mariner Independent Advisor Network’s Takeda Pharmaceutical TAK Stock Holding History

Mariner Independent Advisor Network’s Portfolio TAK Stock Details TAK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-15,524	Closed	-$214K	–	530
2021 Q4	$214K	Buy	15,524 +1,037	+7%	+$14.5K	0.01%	447
2021 Q3	$237K	Sell	14,487 -5,516	-28%	-$92.6K	0.01%	453
2021 Q2	$337K	Sell	20,003 -978	-5%	-$16.6K	0.02%	444
2021 Q1	$383K	Buy	+20,981	New	+$377K	0.02%	393

Other funds holding TAK

PPA

Parametric Portfolio Associates Seattle, Washington $190B AUM 18.52% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

MIP

Mondrian Investment Partners London, United Kingdom $6.48B AUM 18.36% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

BIP

Brandes Investment Partners La Jolla, California $14.3B AUM 23.11% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Mariner Independent Advisor Network's TAK Position: Q1 2022 in Review

Mariner Independent Advisor Network sold out of Takeda Pharmaceutical (TAK) in Q1 2022, closing a stake of 15,524 shares — an estimated $214K sold.

Mariner Independent Advisor Network first reported a position in TAK in Q1 2021 and held it in 4 quarters. The position peaked at $383K in Q1 2021. 288 funds tracked by Wall St. Rank hold TAK as of Q1 2022.

Mariner Independent Advisor Network reported no remaining Takeda Pharmaceutical position as of Q1 2022 after selling out during the quarter.
Mariner Independent Advisor Network sold 15,524 Takeda Pharmaceutical shares in Q1 2022, an estimated $214K.
Mariner Independent Advisor Network first reported a position in Takeda Pharmaceutical in Q1 2021 and held it in 4 quarters.
Mariner Independent Advisor Network's Takeda Pharmaceutical position peaked at $383K in Q1 2021.
288 funds tracked by Wall St. Rank held Takeda Pharmaceutical as of Q1 2022.

Based on Mariner Independent Advisor Network's 13F filing for Q1 2022, filed 10 May 2022.